Search

Charanjit Aulakh

Examiner (ID: 11601)

Most Active Art Unit
1625
Art Unit(s)
1625, 1612, 1203, 1621
Total Applications
3765
Issued Applications
2855
Pending Applications
383
Abandoned Applications
582

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 185179 [patent_doc_number] => 07648995 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-01-19 [patent_title] => 'R(—)-11-hydroxyaporphine derivatives and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/105024 [patent_app_country] => US [patent_app_date] => 2005-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 12639 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/648/07648995.pdf [firstpage_image] =>[orig_patent_app_number] => 11105024 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/105024
R(—)-11-hydroxyaporphine derivatives and uses thereof Apr 12, 2005 Issued
Array ( [id] => 341675 [patent_doc_number] => 07501433 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-10 [patent_title] => 'Opioid and opioid-like compounds and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/104281 [patent_app_country] => US [patent_app_date] => 2005-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12762 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/501/07501433.pdf [firstpage_image] =>[orig_patent_app_number] => 11104281 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/104281
Opioid and opioid-like compounds and uses thereof Apr 11, 2005 Issued
Array ( [id] => 5700870 [patent_doc_number] => 20060217555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'PREPARATION OF CABERGOLINE' [patent_app_type] => utility [patent_app_number] => 11/100934 [patent_app_country] => US [patent_app_date] => 2005-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2302 [patent_no_of_claims] => 72 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20060217555.pdf [firstpage_image] =>[orig_patent_app_number] => 11100934 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/100934
Preparation of cabergoline Apr 6, 2005 Issued
Array ( [id] => 7691397 [patent_doc_number] => 20070232636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-04 [patent_title] => 'Substituted Diaza-Spiro-[5.5]-Undecane Derivaties and Their Use as Neurokinin Antagonists' [patent_app_type] => utility [patent_app_number] => 11/547889 [patent_app_country] => US [patent_app_date] => 2005-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20797 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20070232636.pdf [firstpage_image] =>[orig_patent_app_number] => 11547889 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/547889
Substituted diaza-spiro-[5.5]-undecane derivatives and their use as neurokinin antagonists Apr 3, 2005 Issued
Array ( [id] => 7225262 [patent_doc_number] => 20050261332 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Sulfonamides and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/098315 [patent_app_country] => US [patent_app_date] => 2005-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28766 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0261/20050261332.pdf [firstpage_image] =>[orig_patent_app_number] => 11098315 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/098315
Sulfonamides and uses thereof Apr 3, 2005 Abandoned
Array ( [id] => 758538 [patent_doc_number] => 07015327 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-03-21 [patent_title] => 'Anthrapyridone compounds, water-base magenta ink compositions and method of ink-jet recording' [patent_app_type] => utility [patent_app_number] => 11/096507 [patent_app_country] => US [patent_app_date] => 2005-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9576 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/015/07015327.pdf [firstpage_image] =>[orig_patent_app_number] => 11096507 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/096507
Anthrapyridone compounds, water-base magenta ink compositions and method of ink-jet recording Mar 31, 2005 Issued
Array ( [id] => 8270533 [patent_doc_number] => 08212037 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-03 [patent_title] => 'Process for production of optically active quinuclidinols' [patent_app_type] => utility [patent_app_number] => 11/887340 [patent_app_country] => US [patent_app_date] => 2005-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17892 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11887340 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/887340
Process for production of optically active quinuclidinols Mar 29, 2005 Issued
Array ( [id] => 5754849 [patent_doc_number] => 20060223998 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-05 [patent_title] => 'Synthetic LSD metabolite for preparing haptens used in an LSD metabolite immunoassay' [patent_app_type] => utility [patent_app_number] => 11/093676 [patent_app_country] => US [patent_app_date] => 2005-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 2144 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20060223998.pdf [firstpage_image] =>[orig_patent_app_number] => 11093676 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/093676
Synthetic LSD metabolite for preparing haptens used in an LSD metabolite immunoassay Mar 29, 2005 Abandoned
Array ( [id] => 7020169 [patent_doc_number] => 20050222188 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Process for preparing oxycodone hydrochloride having less than 25 PPM 14-hydroxycodeinone' [patent_app_type] => utility [patent_app_number] => 11/093626 [patent_app_country] => US [patent_app_date] => 2005-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17662 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222188.pdf [firstpage_image] =>[orig_patent_app_number] => 11093626 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/093626
Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone Mar 29, 2005 Issued
Array ( [id] => 4978141 [patent_doc_number] => 20070219375 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => 'Novel Compound and Organic Electronic Device Using the Same' [patent_app_type] => utility [patent_app_number] => 10/594156 [patent_app_country] => US [patent_app_date] => 2005-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 24698 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20070219375.pdf [firstpage_image] =>[orig_patent_app_number] => 10594156 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/594156
Compound and organic electronic device using the same Mar 28, 2005 Issued
Array ( [id] => 415302 [patent_doc_number] => 07279486 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-10-09 [patent_title] => 'Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as ORL1-receptor antagonists' [patent_app_type] => utility [patent_app_number] => 11/092503 [patent_app_country] => US [patent_app_date] => 2005-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 44400 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/279/07279486.pdf [firstpage_image] =>[orig_patent_app_number] => 11092503 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/092503
Alpha aryl or heteroaryl methyl beta piperidino propanoic acid compounds as ORL1-receptor antagonists Mar 28, 2005 Issued
Array ( [id] => 7201183 [patent_doc_number] => 20050165092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Crystalline base of citalopram' [patent_app_type] => utility [patent_app_number] => 11/090336 [patent_app_country] => US [patent_app_date] => 2005-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4757 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20050165092.pdf [firstpage_image] =>[orig_patent_app_number] => 11090336 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/090336
Crystalline base of citalopram Mar 23, 2005 Abandoned
Array ( [id] => 7202038 [patent_doc_number] => 20050165244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Crystalline base of citalopram' [patent_app_type] => utility [patent_app_number] => 11/090337 [patent_app_country] => US [patent_app_date] => 2005-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4756 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20050165244.pdf [firstpage_image] =>[orig_patent_app_number] => 11090337 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/090337
Crystalline base of citalopram Mar 23, 2005 Abandoned
Array ( [id] => 6960091 [patent_doc_number] => 20050215792 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Transition metal complexes' [patent_app_type] => utility [patent_app_number] => 11/088023 [patent_app_country] => US [patent_app_date] => 2005-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23757 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215792.pdf [firstpage_image] =>[orig_patent_app_number] => 11088023 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/088023
Transition metal complexes Mar 22, 2005 Issued
Array ( [id] => 584415 [patent_doc_number] => 07449578 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-11-11 [patent_title] => 'Two-photon absorbing materials with quenched emission' [patent_app_type] => utility [patent_app_number] => 11/087236 [patent_app_country] => US [patent_app_date] => 2005-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 6035 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/449/07449578.pdf [firstpage_image] =>[orig_patent_app_number] => 11087236 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/087236
Two-photon absorbing materials with quenched emission Mar 22, 2005 Issued
Array ( [id] => 7005823 [patent_doc_number] => 20050171136 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Modulators of the glucocorticoid receptor and method' [patent_app_type] => utility [patent_app_number] => 11/085347 [patent_app_country] => US [patent_app_date] => 2005-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26972 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20050171136.pdf [firstpage_image] =>[orig_patent_app_number] => 11085347 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/085347
Modulators of the glucocorticoid receptor and method Mar 20, 2005 Abandoned
Array ( [id] => 6959621 [patent_doc_number] => 20050215590 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Formamide derivatives for the treatment of diseases' [patent_app_type] => utility [patent_app_number] => 11/086035 [patent_app_country] => US [patent_app_date] => 2005-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36056 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215590.pdf [firstpage_image] =>[orig_patent_app_number] => 11086035 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/086035
Formamide derivatives for the treatment of diseases Mar 20, 2005 Issued
Array ( [id] => 5131778 [patent_doc_number] => 20070208175 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-06 [patent_title] => 'PROCESS FOR PREPARING CYCLOHEXANEDIACETIC ACID MONOAMIDE' [patent_app_type] => utility [patent_app_number] => 10/599009 [patent_app_country] => US [patent_app_date] => 2005-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2238 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0208/20070208175.pdf [firstpage_image] =>[orig_patent_app_number] => 10599009 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/599009
Process for preparing cyclohexanediacetic acid monoamide Mar 16, 2005 Issued
Array ( [id] => 5113584 [patent_doc_number] => 20070197500 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-23 [patent_title] => 'Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as orl1-receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/599473 [patent_app_country] => US [patent_app_date] => 2005-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 92413 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20070197500.pdf [firstpage_image] =>[orig_patent_app_number] => 10599473 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/599473
Alpha aryl or heteroaryl methyl beta piperidino propanamide compounds as ORL1-receptor antagonists Mar 15, 2005 Issued
Array ( [id] => 42880 [patent_doc_number] => 07781445 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-24 [patent_title] => 'Synthesis of indenoisoquinoliniums and methods of use' [patent_app_type] => utility [patent_app_number] => 10/592849 [patent_app_country] => US [patent_app_date] => 2005-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13330 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/781/07781445.pdf [firstpage_image] =>[orig_patent_app_number] => 10592849 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/592849
Synthesis of indenoisoquinoliniums and methods of use Mar 14, 2005 Issued
Menu